Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
11.95
+0.06 (0.54%)
At close: Oct 2, 2025
0.54%
Market Cap244.43M
Revenue (ttm)53.00K
Net Income (ttm)-100.73M
Shares Out20.45M
EPS (ttm)-36.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,367
Average Volume9,601
Open12.00
Previous Close11.89
Day's Range11.20 - 12.00
52-Week Range11.20 - 22.50
Betan/a
RSI35.00
Earnings DateNov 6, 2025

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.